ViiV Healthcare sues Gilead over patent

ViiV Healthcare Ltd, the specialist HIV company majority-owned by GlaxoSmithKline Plc, has filed a patent infringement suit against Gilead Sciences Inc over bictegravir, an integrase inhibitor that is part of a combination therapy approved in the US on 7 February.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom